KYLONIB 150MG CAPSULE 4'S

KYLONIB 150MG CAPSULE 4'S may cause liver function abnormalities, which may indicate liver damage. It is important to have regular blood tests to monitor your liver function while taking KYLONIB 150MG CAPSULE 4'S. If you experience symptoms of liver damage, such as jaundice or abdominal pain, you should contact your doctor immediately.

Imatinib, in its selectivity and potency. KYLONIB 150MG CAPSULE 4'S is more selective for the BCR-ABL protein that drives the growth of cancer cells, and it is more potent in inhibiting the activity of this protein. KYLONIB 150MG CAPSULE 4'S has also been shown to be effective in patients who have developed resistance to Imatinib.

The potential long-term effects of KYLONIB 150MG CAPSULE 4'S on the body include cardiovascular events, such as hypertension, arrhythmias, and heart failure, as well as liver dysfunction, pancreatic enzyme elevation, and fluid retention. These side effects are generally rare, but they can occur in some patients.

It is monitored through regular blood tests, electrocardiograms, and imaging studies. Blood tests can assess liver and kidney function, blood counts, and electrolyte levels. ECG can detect any changes in heart rhythm or function. Imaging studies, such as echocardiograms and chest X-rays, can evaluate the heart and lungs for any signs of damage or fluid accumulation.

KYLONIB 150MG CAPSULE 4'S should not be taken by pregnant or breastfeeding women, or by people with certain medical conditions such as severe liver or kidney disease, a history of pancreatitis, or a prolonged QT interval.

There is NULL interaction of KYLONIB 150MG CAPSULE 4'S with other drugs.

Based on your condition your doctor may prescribe a lower dose. KYLONIB 150MG CAPSULE 4'S can be used by people aged 65 years and over with the same dose as other adults. Tell your doctor if you experience any irregular heartbeats or any signs of a heart condition because this can lead to serious complications like sudden death. Inform your physician if you have kidney problems. Your physician will decide whether you may receive this medication after monitoring your kidney functions. Some children and adolescents taking this medicine may have slower than normal growth. So, your doctor will regularly monitor your growth. Report to your doctor if you have had a history of heart failure or hepatitis infection. Discuss effective contraceptive options with your healthcare provider.

NILOTINIB is molecule/combination used for making KYLONIB 150MG CAPSULE 4'S.

KYLONIB 150MG CAPSULE 4'S is prescribed for {Oncology}.